Pfizer Stock Plunges After Earnings Miss and Acquisitions
Pfizer’s stock price dropped sharply after the company reported lower-than-expected earnings. The pharmaceutical giant missed forecasts due to several acquisitions, including the purchase of Metsera for $10 billion. Analysts say it’s not a major surprise, as Pfizer had warned about potential dilution from its new acquisitions. The company expects to earn between $2.80 and $3 … Read more